Role of Lipid Domains in Renal Phosphate Transport
Project Number5K08DK062220-02
Contact PI/Project LeaderZAJICEK, HUBERT K
Awardee OrganizationUT SOUTHWESTERN MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant):
Disorders of extracellular inorganic phosphate (Pi) concentration and impairment in Pi reabsorption are common clinical problems in the general population. Aging, diabetes mellitus, malignancy, alcoholism, post-organ transplantation, AIDS, and several therapeutic drugs are well known to cause or to be associated with hypophosphatemia or hyperphosphatemia, mainly by affecting renal tubular Pi transport. The kidney plays a critical role in the regulation of Pi homeostasis. Pi is freely filtered across the glomerulus and most of the Pi is reabsorbed along the proximal tubule via a sodium gradient-dependent process (Na/Pi cotransport). The Na/Pi cotransporter is located on the apical brush border membrane (BBM) of the proximal tubule. The evidence to date indicates that regulation of the overall renal tubular Pi transport by dietary, hormonal, or metabolic factors occurs at the level of the proximal tubular BBM Na/Pi cotransport system.
The specific aims of this proposal are to determine: 1) the role of lipid microdomains/ lipid rafts, alterations in the diffusion and/or clustering of Na/Pi proteins in the regulation of Na/Pi cotransport activity, 2) the role of clathrin, caveolae and dynamin in trafficking; specifically, internalization of Na/Pi protein from the apical membrane, 3) the role of SNAREs in trafficking, especially targeting of Na/Pi protein to the apical membrane and 4) the effect of direct alterations in cholesterol content on these processes of lateral and vertical diffusion of Na/Pi Protein.
The models utilized will consist of Pi-adaptation and modification of cholesterol content, in Oppossum Kidney Cells (OK), a cell culture line. The methods employed will range from well-known biochemical approaches of transport rate, protein measurements and biotinylation experiments to newer biophysical techniques of imaging and co-localization such as Fluorescence Resonance Energy Transfer (FRET) and Fluorescence Correlation Spectroscopy (FCS) and Confocal Immunofluorescence Microscopy.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
849
DUNS Number
800771545
UEI
YZJ6DKPM4W63
Project Start Date
21-August-2002
Project End Date
30-June-2007
Budget Start Date
01-July-2003
Budget End Date
30-June-2004
Project Funding Information for 2003
Total Funding
$124,200
Direct Costs
$115,000
Indirect Costs
$9,200
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Diabetes and Digestive and Kidney Diseases
$124,200
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5K08DK062220-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5K08DK062220-02
Patents
No Patents information available for 5K08DK062220-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5K08DK062220-02
Clinical Studies
No Clinical Studies information available for 5K08DK062220-02
News and More
Related News Releases
No news release information available for 5K08DK062220-02
History
No Historical information available for 5K08DK062220-02
Similar Projects
No Similar Projects information available for 5K08DK062220-02